Follow-The-Filings

Security · featured owners

AMGN Amgen Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 7 Owners
  • #296
  • Max 3.0%
  • Master 0.00%
  • $69M
  • 1 new 2 add 3 reduce

AMGN (Amgen Inc.) is held in 7 featured 13F books as of 2026 Q2. David Katz - Matrix Asset Advisors is the largest tracked holder by portfolio weight (3.0%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 3.0% (David Katz - Matrix Asset Advisors) · not free-float ownership

  1. David Katz add 3.0%
  2. Torray Investment Partners add 2.9%
  3. Kentucky Trust Co. 0.82%
  4. Steven Check new 0.04%
  5. Mairs & Power reduce 0.02%
  6. Murray Stahl reduce 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Katz - Matrix Asset Advisors 2026 Q2 3.0% Add +3.0% 102,817 $37M history
Torray Investment Partners 2026 Q2 2.9% Add +10.7% 59,771 $22M history
Dodge & Cox 2026 Q2 <0.01% Reduce −4.1% 12,817 $5M history
Mairs & Power 2026 Q2 0.02% Reduce −0.8% 4,924 $2M history
Kentucky Trust Co. - Kentucky Trust 2026 Q2 0.82% Hold 4,717 $2M history
Steven Check - Check Capital Management 2026 Q2 0.04% New 0.04% 3,885 $1M history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 0.01% Reduce −4.1% 2,300 $833K history

7 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 5 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.05 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 6 rows shown

Filed Form Detail Links
4 Period Aug 11, 2026 Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Aug 7, 2026 · 3 forms Filing Doc
4 Period Aug 6, 2026 · 2 forms Filing Doc
4 Period May 19, 2026 · 11 forms Filing Doc
4 Period May 7, 2026 · 7 forms Filing Doc

Updated about 1 month ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $28.19B $33.42B $36.75B
Gross profit * $19.74B $20.57B $24.71B
Gross margin * 70.0% 61.5% 67.2%
Net income $6.72B $4.09B $7.71B
Net margin * 23.8% 12.2% 21.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $30.33B $29.03B $29.06B
Total non-current assets * $66.82B $62.81B $61.53B
Total assets $97.15B $91.84B $90.59B
Total current liabilities $18.39B $23.1B $25.49B
Total equity $6.23B $5.88B $8.66B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $8.47B $11.49B $9.96B
Cash from investing -$26.2B -$1.05B -$1.94B
Cash from financing $21.05B -$9.42B -$10.86B
Net change in cash $3.32B $1.03B -$2.84B

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders